Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis.
about
Mycobacterial di-O-acyl-trehalose inhibits mitogen- and antigen-induced proliferation of murine T cells in vitroCompartmentalized bronchoalveolar IFN-gamma and IL-12 response in human pulmonary tuberculosisGlutathione and adaptive immune responses against Mycobacterium tuberculosis infection in healthy and HIV infected individualsExpression of virulence of Mycobacterium tuberculosis within human monocytes: virulence correlates with intracellular growth and induction of tumor necrosis factor alpha but not with evasion of lymphocyte-dependent monocyte effector functions.T-Cell hyporesponsiveness induced by activated macrophages through nitric oxide production in mice infected with Mycobacterium tuberculosis.Dichotomy of cytokine profiles in patients and high-risk healthy subjects exposed to tuberculosisInterleukin-2 and loss of immunity in experimental Mycobacterium avium infectionExpression of functional interleukin 2 receptors by peripheral blood monocytes from patients with active pulmonary tuberculosis.Generalized immunological decline during long-term experimental infection with Mycobacterium avium.Cellular immune responses in HIV-negative immunodeficiency with anti-interferon-γ antibodies and opportunistic intracellular microorganisms.Foxp3+ regulatory T cells among tuberculosis patients: impact on prognosis and restoration of antigen specific IFN-γ producing T cells.T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy.Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controlsEffects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells/mm3Effect of Mycobacterium bovis BCG vaccination on Mycobacterium-specific cellular proliferation and tumor necrosis factor alpha production from distinct guinea pig leukocyte populations.Dietary protein deficiency and Mycobacterium bovis BCG affect interleukin-2 activity in experimental pulmonary tuberculosis.Changes of plasma interleukin-1 receptor antagonist, interleukin-8 and other serologic markers during chemotherapy in patients with active pulmonary tuberculosis.Immunoregulatory biological response modifiers: effect of cytokines on septic shockThe immuno-endocrine component in the pathogenesis of tuberculosis.Immunomodulation of mouse macrophage killing of Mycobacterium avium in vitroRecombinant interleukin-2 limits the replication of Mycobacterium lepraemurium and Mycobacterium bovis BCG in mice.Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis.Cross-modulation by transforming growth factor beta in human tuberculosis: suppression of antigen-driven blastogenesis and interferon gamma production.Immunoregulation in TB: observations and implicationsCytokine therapy of tuberculosis at the crossroads.Immunotherapy for TB.Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis.Ineffective cellular immune response associated with T-cell apoptosis in susceptible Mycobacterium bovis BCG-infected mice.Altered cytokine production and impaired antimycobacterial immunity in protein-malnourished guinea pigsSelective increases in antibody isotypes and immunoglobulin G subclass responses to secreted antigens in tuberculosis patients and healthy household contacts of the patients.Cytokine gene expression by cultures of human lymphocytes with autologous Mycobacterium tuberculosis-infected monocytesRecombinant human interleukin-2 reverses in vitro-deficient cell-mediated immune responses to tuberculin purified protein derivative by lymphocytes of tuberculous patients.Restimulation-induced T-cell death through NTB-A/SAP signaling pathway is impaired in tuberculosis patients with depressed immune responses.Activation of NF-kappaB in Mycobacterium tuberculosis- induced interleukin-2 receptor expression in mononuclear phagocytes.Immunological responses in patients with tuberculosis and in vivo effects of acetyl-L-carnitine oral administration.OMIP-022: Comprehensive assessment of antigen-specific human T-cell functionality and memory.Apoptosis of CD4+ and CD8+ T cells during experimental infection with Mycobacterium avium is controlled by Fas/FasL and Bcl-2-sensitive pathways, respectively.Immunotherapy for tuberculosis: wave of the future or tilting at windmills?Induction of non-specific immunosuppression in mice by mycobacterial infections and its relationship to macrophage activation.Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens
P2860
Q28362936-B453D1DE-6FC8-49CE-9AB6-1F710FA1D14DQ28387743-D4EE6D4E-F356-4960-8004-69409ACBDEB8Q28741997-987F3E93-ADB5-414B-A273-83FF08F45FCAQ33751770-907E66E9-56BE-48D5-B658-669E688256C7Q33876250-599BF572-4E58-4C8C-A207-9E4FDBC1B185Q34002304-721EA853-C7E7-41BD-B6DF-5C017D4CB56BQ34115948-2F6C8030-F673-41D7-A3DB-BF6585C74F1EQ34252586-5850724B-B44E-43BC-8028-537CC3F33E68Q34258025-B13CB2E3-0F6A-4168-AB3A-50E5E7D2A498Q34374089-B9BCB4FC-752A-42F8-9EFF-0CBB4D255D06Q34427311-15861C06-C7F7-41EC-B21D-2AE6E337DDC8Q34536007-ADEE2EF4-E908-4980-885D-19898CA9AC7FQ34549525-BE8D4F49-2C98-4199-9CC5-2FC01945CDF9Q34743386-836FA8DA-9E57-4786-82F8-4D44ADDA253AQ34942177-6A23E6BB-CB2B-4280-9600-B4EF8CFC5E31Q35101314-EE31C9C6-AEA1-42CC-A23B-A8710A90DD93Q35937184-EBCCD19E-6D6C-4DC0-BE96-7AC71344570EQ36627156-58205AEF-A2A4-4FC6-845B-F73FBC31E504Q36884501-C1A4BCE9-8E28-4A31-9E9E-B91E2D11BA5FQ36961332-39A55456-9A59-4714-AC93-508873DC080EQ36994895-A3FE24F7-E92E-4EF7-8EFC-5C71FA256CA0Q37427183-004B9D46-47B8-46F6-AA55-6658EC29703AQ37644073-AA9A208E-9F8E-4192-A83A-AB8184B56043Q37742701-D26255C7-1514-407B-8514-9979781269A4Q37754962-25A26144-3A02-498C-9D85-AC82771B7AD0Q38025666-F9F48E56-470C-48FE-9420-C96BB925BD6CQ38883295-908C4401-0EE2-47C0-A110-924E9E375E6BQ39537932-B390A3ED-8B12-4CA2-8E0C-876F5E1FB507Q39572180-3050C856-5722-4BFD-AB47-F74D125A82FEQ39810010-DF1DC175-4304-4AAB-9B3D-90D839164D4DQ39859774-C8337D08-5C0F-4ADE-A11F-F06AA83A4B9AQ40164059-FAF3FFE5-CA72-4E2C-8D39-C527B9BA9126Q40197875-AEBC4975-FEE4-41C5-9287-6DB54BCC07A6Q40962455-4106B0F1-ECD9-4DDC-AF5E-ED2C7FC0BAD5Q41901789-BFEDE023-7F40-435E-B589-44A5870C2824Q43005485-35F4083E-0FF9-4706-BEA2-3D1F8FB255D7Q43838631-3226FC7A-FDAC-4239-BEBD-8E52E533CCE8Q53924348-66A52A6D-9C36-4D35-A98B-81A66DDF4259Q54347594-6F7B9E5A-0ABC-4620-8943-A240740410B4Q56828019-34C1949B-55A8-4F0A-BFF9-FB86D70D3E9A
P2860
Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis.
@ast
Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis.
@en
type
label
Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis.
@ast
Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis.
@en
prefLabel
Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis.
@ast
Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis.
@en
P2860
P356
P1476
Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis
@en
P2093
M E Kleinhenz
P2860
P304
P356
10.1084/JEM.163.5.1162
P407
P577
1986-05-01T00:00:00Z